ProBioGen AG
ProBioGen AG is an international Contract Development and Manufacturing Organization (CDMO) based in Berlin, Germany, with over 30 years of experience in the biopharmaceutical sector. Founded in 1994, the company specializes in developing and manufacturing complex biopharmaceutical active ingredients, including therapeutic proteins and viral vectors for vaccines and gene therapy products. ProBioGen offers a range of end-to-end CDMO services, including cell line engineering, process development, GMP manufacturing, and innovative analytical development. Their proprietary technologies, such as the CHO.RiGHT® expression system and GlymaxX® technology, enhance protein production and glycosylation control. The company is known for its scientific excellence and commitment to quality, supported by experienced managers who work closely with clients to customize solutions. With a global clientele of biotech and pharmaceutical companies, ProBioGen emphasizes a collaborative work environment and actively participates in major industry events. Their focus on innovation and professional growth positions them as a key player in the biopharmaceutical industry.
Work at ProBioGen AG in HR or recruiting? Claim this page
Headcount trend
ProBioGen AG went from 3 employees in Oct 2024 to 3 in Sep 2026.
Org structure
Headcount by department
Peer reviews
Worked with someone at ProBioGen AG?
Anonymous peer reviews on OffTheRecord
Similar companies
ProBioGen AG FAQ
How many employees does ProBioGen AG have?
ProBioGen AG has about 3 employees, unchanged over the 3 months to Sep 2026.
What is ProBioGen AG's revenue per employee?
ProBioGen AG makes about $21M in revenue per employee, based on $63M annual revenue and 3 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.